{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:49:27Z","timestamp":1793969367029,"version":"4.8.0"},"reference-count":151,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2014,4,29]]},"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study was to characterise the incidence rates of herpes zoster (HZ), also known as shingles, and risk of complications across the world.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We systematically reviewed studies examining the incidence rates of HZ, temporal trends of HZ, the risk of complications including postherpetic neuralgia (PHN) and HZ-associated hospitalisation and mortality rates in the general population. The literature search was conducted using PubMed, EMBASE and the WHO library up to December 2013.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 130 studies conducted in 26 countries. The incidence rate of HZ ranged between 3 and 5\/1000 person-years in North America, Europe and Asia-Pacific, based on studies using prospective surveillance, electronic medical record data or administrative data with medical record review. A temporal increase in the incidence of HZ was reported in the past several decades across seven countries, often occurring before the introduction of varicella vaccination programmes. The risk of developing PHN varied from 5% to more than 30%, depending on the type of study design, age distribution of study populations and definition. More than 30% of patients with PHN experienced persistent pain for more than 1\u2005year. The risk of recurrence of HZ ranged from 1% to 6%, with long-term follow-up studies showing higher risk (5\u20136%). Hospitalisation rates ranged from 2 to 25\/100\u2005000 person-years, with higher rates among elderly populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HZ is a significant global health burden that is expected to increase as the population ages. Future research with rigorous methods is important.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2014-004833","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T01:07:31Z","timestamp":1402448851000},"page":"e004833","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":814,"title":["Systematic review of incidence and complications of herpes zoster: towards a global perspective"],"prefix":"10.1136","volume":"4","author":[{"given":"Kosuke","family":"Kawai","sequence":"first","affiliation":[{"name":"Global Health Outcomes, Merck & Co., Inc., West Point, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berhanu G","family":"Gebremeskel","sequence":"additional","affiliation":[{"name":"School of Public Health, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo J","family":"Acosta","sequence":"additional","affiliation":[{"name":"Global Health Outcomes, Merck & Co., Inc., West Point, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"key":"2025120518553364000_4.6.e004833.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1302674"},{"key":"2025120518553364000_4.6.e004833.2","doi-asserted-by":"publisher","DOI":"10.1086\/510206"},{"key":"2025120518553364000_4.6.e004833.3","doi-asserted-by":"publisher","DOI":"10.4065\/82.11.1341"},{"key":"2025120518553364000_4.6.e004833.4","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc R Soc Med"},{"key":"2025120518553364000_4.6.e004833.5","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-37"},{"key":"2025120518553364000_4.6.e004833.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"2025120518553364000_4.6.e004833.7","unstructured":"World Population Prospects: The 2012 Revision. United Nations, Department of Economic and Social Affairs, Population Division, 2013."},{"key":"2025120518553364000_4.6.e004833.8","unstructured":"World report on disability. World Health Organization and the World Bank, 2011."},{"key":"2025120518553364000_4.6.e004833.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00857-0"},{"issue":"(Suppl 2)","key":"2025120518553364000_4.6.e004833.10","first-page":"40","article-title":"Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America","volume":"14","author":"Ara\u00fajo","year":"2007","journal-title":"Herpes"},{"key":"2025120518553364000_4.6.e004833.11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systematic literature review","volume":"13","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2025120518553364000_4.6.e004833.12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","article-title":"Population-based study of herpes zoster and its sequelae","volume":"61","author":"Ragozzino","year":"1982","journal-title":"Medicine (Baltimore)"},{"key":"2025120518553364000_4.6.e004833.13","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1995.00430150071008"},{"key":"2025120518553364000_4.6.e004833.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0150.x"},{"key":"2025120518553364000_4.6.e004833.15","doi-asserted-by":"publisher","DOI":"10.1017\/S095026880400281X"},{"key":"2025120518553364000_4.6.e004833.16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-5-68"},{"key":"2025120518553364000_4.6.e004833.17","doi-asserted-by":"publisher","DOI":"10.1086\/430325"},{"key":"2025120518553364000_4.6.e004833.18","doi-asserted-by":"publisher","DOI":"10.1086\/651078"},{"key":"2025120518553364000_4.6.e004833.19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq077"},{"key":"2025120518553364000_4.6.e004833.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1983"},{"key":"2025120518553364000_4.6.e004833.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001420"},{"key":"2025120518553364000_4.6.e004833.22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s15010-013-0550-8","article-title":"Incidence of herpes zoster in patients with altered immune function","volume":"42","author":"Chen","year":"2014","journal-title":"Infection"},{"key":"2025120518553364000_4.6.e004833.23","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-11-201312030-00006"},{"key":"2025120518553364000_4.6.e004833.24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster virus infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"key":"2025120518553364000_4.6.e004833.25","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268807007893"},{"key":"2025120518553364000_4.6.e004833.26","first-page":"1","article-title":"The burden of varicella and zoster in British Columbia 1994\u20132003: baseline assessment prior to universal vaccination","volume":"33","author":"Edgar","year":"2007","journal-title":"Can Commun Dis Rep"},{"key":"2025120518553364000_4.6.e004833.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.024"},{"key":"2025120518553364000_4.6.e004833.28","doi-asserted-by":"crossref","unstructured":"Russell ML Dover DC Simmonds KA . Shingles in Alberta: before and after publicly funded varicella vaccination. Vaccine 2013. doi:10.1016\/j.vaccine.2013.09.018. [Epub ahead of print 4 Oct 2013].","DOI":"10.1016\/j.vaccine.2013.09.018"},{"key":"2025120518553364000_4.6.e004833.29","first-page":"29","article-title":"Herpes zoster in general practice","volume":"25","author":"Ross","year":"1975","journal-title":"J R Coll Gen Pract"},{"key":"2025120518553364000_4.6.e004833.30","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10313"},{"key":"2025120518553364000_4.6.e004833.31","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268803001523"},{"key":"2025120518553364000_4.6.e004833.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00034-3"},{"key":"2025120518553364000_4.6.e004833.33","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10316"},{"key":"2025120518553364000_4.6.e004833.34","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268808000678"},{"key":"2025120518553364000_4.6.e004833.35","doi-asserted-by":"publisher","DOI":"10.1086\/320884"},{"key":"2025120518553364000_4.6.e004833.36","first-page":"497","article-title":"[Herpes zoster: incidence study among \u201csentinel\u201d general practitioners]","volume":"128","author":"Czernichow","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"2025120518553364000_4.6.e004833.37","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1016\/j.vaccine.2010.09.074","article-title":"Herpes zoster: burden of disease in France","volume":"28","author":"Gonzalez Chiappe","year":"2010","journal-title":"Vaccine"},{"key":"2025120518553364000_4.6.e004833.38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.respe.2010.06.166","article-title":"[Burden of herpes zoster and postherpetic neuralgia: incidence, proportion, and associated costs in the French population aged 50 or over]","volume":"58","author":"Mick","year":"2010","journal-title":"Rev Epidemiol Sante Publique"},{"key":"2025120518553364000_4.6.e004833.39","doi-asserted-by":"publisher","DOI":"10.1007\/s001050050476"},{"issue":"(Suppl 4)","key":"2025120518553364000_4.6.e004833.40","first-page":"193","article-title":"[Herpes zoster in Germany. A retrospective analyse of SHL data]","volume":"151","author":"Schiffner-Rohe","year":"2010","journal-title":"MMW Fortschr Med"},{"key":"2025120518553364000_4.6.e004833.41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-173"},{"key":"2025120518553364000_4.6.e004833.42","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10198-012-0452-1","article-title":"Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany","volume":"14","author":"Ultsch","year":"2013","journal-title":"Eur J Health Econ"},{"key":"2025120518553364000_4.6.e004833.43","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/19.5.471"},{"key":"2025120518553364000_4.6.e004833.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.02.017"},{"key":"2025120518553364000_4.6.e004833.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2005.12.002"},{"key":"2025120518553364000_4.6.e004833.46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2334-12-110","article-title":"Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands","volume":"12","author":"Pierik","year":"2012","journal-title":"BMC Infect Dis"},{"key":"2025120518553364000_4.6.e004833.47","unstructured":"Richard J-L Zimmermann H . Herp\u00e8s zoster 1998\u20132001. Sentinella-Jahresbericht ; 2001."},{"key":"2025120518553364000_4.6.e004833.48","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","article-title":"The health and economic burden of chickenpox and herpes zoster in Belgium","volume":"140","author":"Bilcke","year":"2012","journal-title":"Epidemiol Infect"},{"key":"2025120518553364000_4.6.e004833.49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-7-59"},{"key":"2025120518553364000_4.6.e004833.50","first-page":"71","article-title":"[Varicella and herpes zoster incidence prior to the introduction of systematic child vaccination in Navarre, 2005\u20132006]","volume":"31","author":"Garc\u00eda Cenoz","year":"2008","journal-title":"An Sist Sanit Navar"},{"key":"2025120518553364000_4.6.e004833.51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2296-11-33","article-title":"Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain)","volume":"11","author":"Cebri\u00e1n-Cuenca","year":"2010","journal-title":"BMC Fam Pract"},{"key":"2025120518553364000_4.6.e004833.52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/1471-2334-13-463","article-title":"Herpes zoster surveillance using electronic databases in the Valencian community (Spain)","volume":"13","author":"Morant-Talamante","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2025120518553364000_4.6.e004833.53","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jinf.2013.09.035","article-title":"Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005\u20132012","volume":"68","author":"Esteban-Vasallo","year":"2014","journal-title":"J Infect"},{"key":"2025120518553364000_4.6.e004833.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(99)90079-8"},{"key":"2025120518553364000_4.6.e004833.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.049"},{"key":"2025120518553364000_4.6.e004833.56","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-230"},{"key":"2025120518553364000_4.6.e004833.57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/13814789609161651","article-title":"The clinical course of herpes zoster: a prospective study in primary care","volume":"2","author":"Helgason","year":"1996","journal-title":"Eur J Gen Pract"},{"key":"2025120518553364000_4.6.e004833.58","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/1471-2334-13-586","article-title":"Disease burden of herpes zoster in Sweden\u2014predominance in the elderly and in women\u2014a register based study","volume":"13","author":"Studahl","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2025120518553364000_4.6.e004833.59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2296-12-136","article-title":"Measuring the burden of herpes zoster and post herpetic neuralgia within primary care in rural Crete, Greece","volume":"12","author":"Lionis","year":"2011","journal-title":"BMC Fam Pract"},{"key":"2025120518553364000_4.6.e004833.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.06.016"},{"key":"2025120518553364000_4.6.e004833.61","first-page":"457","article-title":"Herpes zoster in eastern Saudi Arabia: clinical presentation and management","volume":"7","author":"Alakloby","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"2025120518553364000_4.6.e004833.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.11.012"},{"key":"2025120518553364000_4.6.e004833.63","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0729"},{"key":"2025120518553364000_4.6.e004833.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.11.029"},{"key":"2025120518553364000_4.6.e004833.65","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268811001786"},{"key":"2025120518553364000_4.6.e004833.66","first-page":"1531","article-title":"A clinical study on herpes zoster during the last 10-year-period (1994\u20132003)","volume":"42","author":"Park","year":"2004","journal-title":"Korean J Dermatol"},{"key":"2025120518553364000_4.6.e004833.67","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcv.2010.01.003","article-title":"Disease burden of herpes zoster in Korea","volume":"47","author":"Choi","year":"2010","journal-title":"J Clin Virol"},{"key":"2025120518553364000_4.6.e004833.68","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21599"},{"key":"2025120518553364000_4.6.e004833.69","first-page":"125","article-title":"[Clinical and epidemiological aspects of herpes zoster]","volume":"68","author":"Vujacich","year":"2008","journal-title":"Medicina (B Aires)"},{"key":"2025120518553364000_4.6.e004833.70","first-page":"129","article-title":"Zoster: mais frequentes entre jovens que entre idosos\/zoster: is more frequent among youngers than aged","volume":"65","author":"Castro","year":"1990","journal-title":"An Bras Dermatol"},{"key":"2025120518553364000_4.6.e004833.71","first-page":"287","article-title":"Herpes zoster y cancer: relaciones entre estas dos enfermedades\/herpes zoster and cancer: relationship between these 2 diseases","volume":"6","author":"Gaitan","year":"1981","journal-title":"Acta Med Colomb"},{"key":"2025120518553364000_4.6.e004833.72","doi-asserted-by":"publisher","DOI":"10.1086\/591975"},{"key":"2025120518553364000_4.6.e004833.73","doi-asserted-by":"publisher","DOI":"10.1086\/591132"},{"key":"2025120518553364000_4.6.e004833.74","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181a90b16"},{"key":"2025120518553364000_4.6.e004833.75","unstructured":"Yawn B Wollan P Bialek S . Trends in herpes zoster prevalence in a population based cohort from 1945 to 2008. 48th Annual Meeting of the Infectious Diseases Society of America. 2010."},{"key":"2025120518553364000_4.6.e004833.76","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1017\/S0950268803008690","article-title":"Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia","volume":"131","author":"MacIntyre","year":"2003","journal-title":"Epidemiol Infect"},{"key":"2025120518553364000_4.6.e004833.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.01.036"},{"key":"2025120518553364000_4.6.e004833.78","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5694\/j.1326-5377.2010.tb03818.x","article-title":"Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine","volume":"193","author":"Nelson","year":"2010","journal-title":"Med J Aust"},{"key":"2025120518553364000_4.6.e004833.79","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268810001949"},{"key":"2025120518553364000_4.6.e004833.80","doi-asserted-by":"crossref","first-page":"e77709","DOI":"10.1371\/journal.pone.0077709","article-title":"Varicella vaccination alters the chronological trends of herpes zoster and varicella","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS ONE"},{"key":"2025120518553364000_4.6.e004833.81","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440320105010"},{"key":"2025120518553364000_4.6.e004833.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.09.021"},{"key":"2025120518553364000_4.6.e004833.83","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2011.0305"},{"key":"2025120518553364000_4.6.e004833.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.07.006"},{"key":"2025120518553364000_4.6.e004833.85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.02.020"},{"key":"2025120518553364000_4.6.e004833.86","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1212\/01.WNL.0000123261.00004.29","article-title":"Risk factors for postherpetic neuralgia in patients with herpes zoster","volume":"62","author":"Jung","year":"2004","journal-title":"Neurology"},{"key":"2025120518553364000_4.6.e004833.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2005.11.002"},{"key":"2025120518553364000_4.6.e004833.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.10.026"},{"key":"2025120518553364000_4.6.e004833.89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02770836","article-title":"A prognostic score for postherpetic neuralgia in ambulatory patients","volume":"26","author":"Meister","year":"1998","journal-title":"Infection"},{"key":"2025120518553364000_4.6.e004833.90","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10389-010-0323-0","article-title":"Impact of herpes zoster and post-herpetic neuralgia on patients\u2019 quality of life: a patient-reported outcomes survey","volume":"18","author":"Weinke","year":"2010","journal-title":"Z Gesundh Wiss"},{"key":"2025120518553364000_4.6.e004833.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.02.004"},{"key":"2025120518553364000_4.6.e004833.92","doi-asserted-by":"crossref","first-page":"449","DOI":"10.33588\/rn.5508.2012298","article-title":"[Incidence, resource use and costs associated with postherpetic neuralgia: a population-based retrospective study]","volume":"55","author":"Sicras-Mainar","year":"2012","journal-title":"Rev Neurol"},{"key":"2025120518553364000_4.6.e004833.93","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1471-2334-11-302","article-title":"Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain","volume":"11","author":"Cebri\u00e1n-Cuenca","year":"2011","journal-title":"BMC Infect Dis"},{"key":"2025120518553364000_4.6.e004833.94","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/jmv.21254","article-title":"Clinical and psychosocial correlates of post-herpetic neuralgia","volume":"80","author":"Volpi","year":"2008","journal-title":"J Med Virol"},{"key":"2025120518553364000_4.6.e004833.95","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1741-7015-8-58","article-title":"Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy","volume":"8","author":"Parruti","year":"2010","journal-title":"BMC Med"},{"key":"2025120518553364000_4.6.e004833.96","doi-asserted-by":"crossref","first-page":"A343","DOI":"10.1016\/j.jval.2013.08.124","article-title":"Predictor factors for the presence of post herpetic neuralgia at 3\u2005months in herpes zoster patients aged 50 and over in Italy: results from a gp-based observational prospective multicenter study","volume":"16","author":"Bricout","year":"2013","journal-title":"Value Health"},{"key":"2025120518553364000_4.6.e004833.97","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7264.794"},{"key":"2025120518553364000_4.6.e004833.98","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10389-011-0481-8","article-title":"The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries","volume":"20","author":"Lukas","year":"2012","journal-title":"J Public Health(Germany)"},{"key":"2025120518553364000_4.6.e004833.99","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.ijid.2012.05.264","article-title":"Assessment of burden of illness due to herpes zoster and predictors of outcomes in Taiwan: a prospective observational study","volume":"16","author":"Tsai","year":"2012","journal-title":"Int J Infect Dis"},{"key":"2025120518553364000_4.6.e004833.100","doi-asserted-by":"publisher","DOI":"10.1177\/147323000203000109"},{"key":"2025120518553364000_4.6.e004833.101","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1742-1241.2006.01155.x","article-title":"The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster","volume":"61","author":"Kurokawa","year":"2007","journal-title":"Int J Clin Pract"},{"key":"2025120518553364000_4.6.e004833.102","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e318243ee01"},{"key":"2025120518553364000_4.6.e004833.103","first-page":"10","article-title":"A clinical study on 2096 patients with herpes zoster during the four-year-period (2007\u20132011)","volume":"39","author":"Ro","year":"2012","journal-title":"J Dermatol"},{"key":"2025120518553364000_4.6.e004833.104","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.ijid.2012.05.255","article-title":"Measuring herpes zoster and post-herpetic neuralgia associated burden of illness and health care utilization and costs in Korea: a clinical epidemiological study","volume":"16","author":"Song","year":"2012","journal-title":"Int J Infect Dis"},{"key":"2025120518553364000_4.6.e004833.105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpain.2013.10.006","article-title":"Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study","volume":"15","author":"Cho","year":"2014","journal-title":"J Pain"},{"key":"2025120518553364000_4.6.e004833.106","first-page":"678","article-title":"Herpes zoster, clinical course and associated diseases: a 5-year retrospective study at Tamathibodi Hospital","volume":"88","author":"Tunsuriyawong","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"2025120518553364000_4.6.e004833.107","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-4632.2010.04715.x","article-title":"Measuring herpes zoster, zoster-associated pain, post-herpetic neuralgia-associated loss of quality of life, and healthcare utilization and costs in Thailand","volume":"50","author":"Aunhachoke","year":"2011","journal-title":"Int J Dermatol"},{"key":"2025120518553364000_4.6.e004833.108","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00241.x"},{"key":"2025120518553364000_4.6.e004833.109","first-page":"213","article-title":"A clinico-epidemiologic profile of herpes zoster in North India","volume":"53","author":"Chaudhary","year":"1987","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2025120518553364000_4.6.e004833.110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/0019-5154.87148","article-title":"Herpes zoster: a clinical study in 205 patients","volume":"56","author":"Abdul Latheef","year":"2011","journal-title":"Indian J Dermatol"},{"key":"2025120518553364000_4.6.e004833.111","doi-asserted-by":"crossref","first-page":"A668","DOI":"10.1016\/j.jval.2013.08.1925","article-title":"Assessment of burden of illness due to herpes zoster in Argentina: a prospective observational study","volume":"16","author":"Vujacich","year":"2013","journal-title":"Value Health"},{"key":"2025120518553364000_4.6.e004833.112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.01.359"},{"key":"2025120518553364000_4.6.e004833.113","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.pain.2013.04.015","article-title":"Natural history of herpes zoster: late follow-up of 3.9 years (n=43) and 7.7 years (n=10)","volume":"154","author":"Reda","year":"2013","journal-title":"Pain"},{"key":"2025120518553364000_4.6.e004833.114","doi-asserted-by":"publisher","DOI":"10.1046\/j.1533-2500.2002.02039.x"},{"key":"2025120518553364000_4.6.e004833.115","first-page":"571","article-title":"Postherpetic neuralgia","volume":"25","author":"Hope-Simpson","year":"1975","journal-title":"J R Coll Gen Pract"},{"key":"2025120518553364000_4.6.e004833.116","doi-asserted-by":"publisher","DOI":"10.1016\/S1090-3801(99)90015-0"},{"key":"2025120518553364000_4.6.e004833.117","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jinf.2009.09.008","article-title":"A 9 year follow up of post herpetic neuralgia and predisposing factors in elderly patients following herpes zoster","volume":"59","author":"McKendrick","year":"2009","journal-title":"J Infect"},{"key":"2025120518553364000_4.6.e004833.118","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afj048"},{"key":"2025120518553364000_4.6.e004833.119","first-page":"378","article-title":"Recurrences in herpes zoster","volume":"26","author":"Epstein","year":"1980","journal-title":"Cutis"},{"key":"2025120518553364000_4.6.e004833.120","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0618"},{"key":"2025120518553364000_4.6.e004833.121","first-page":"287","article-title":"Recurrence rate of herpes zoster during the previous decade","volume":"50","author":"Jeong","year":"2012","journal-title":"Korean J Dermatol"},{"key":"2025120518553364000_4.6.e004833.122","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis334"},{"key":"2025120518553364000_4.6.e004833.123","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.ophtha.2011.04.002","article-title":"Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years","volume":"118","author":"Ghaznawi","year":"2011","journal-title":"Ophthalmology"},{"key":"2025120518553364000_4.6.e004833.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.007"},{"key":"2025120518553364000_4.6.e004833.125","doi-asserted-by":"publisher","DOI":"10.1086\/513626"},{"key":"2025120518553364000_4.6.e004833.126","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.10.009"},{"key":"2025120518553364000_4.6.e004833.127","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0420.2003.00057.x"},{"key":"2025120518553364000_4.6.e004833.128","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1983.01040010044004"},{"key":"2025120518553364000_4.6.e004833.129","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.71.5.353"},{"key":"2025120518553364000_4.6.e004833.130","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.03.014"},{"key":"2025120518553364000_4.6.e004833.131","doi-asserted-by":"publisher","DOI":"10.1086\/315492"},{"key":"2025120518553364000_4.6.e004833.132","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200107000-00002"},{"key":"2025120518553364000_4.6.e004833.133","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2004.04.004","article-title":"Epidemiology of severe varicella-zoster virus infection in Spain","volume":"22","author":"Gil","year":"2004","journal-title":"Vaccine"},{"key":"2025120518553364000_4.6.e004833.134","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-9-55","article-title":"Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998\u20132004)","volume":"9","author":"Gil","year":"2009","journal-title":"BMC Infect Dis"},{"key":"2025120518553364000_4.6.e004833.135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1576-9887(11)70019-X","article-title":"Hospitalizations due to herpes zoster and postherpetic neuralgia in Catalonia, 1998\u20132003","volume":"12","author":"Bayas","year":"2011","journal-title":"Vacunas"},{"key":"2025120518553364000_4.6.e004833.136","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2013.11.008","article-title":"Different vaccination strategies in Spain and its impact on severe varicella and zoster","volume":"32","author":"Gil-Prieto","year":"2014","journal-title":"Vaccine"},{"key":"2025120518553364000_4.6.e004833.137","doi-asserted-by":"crossref","first-page":"531","DOI":"10.20344\/amp.312","article-title":"Hospital admissions for herpes zoster in Portugal between 2000 and 2010","volume":"26","author":"Mesquita","year":"2013","journal-title":"Acta Med Port"},{"key":"2025120518553364000_4.6.e004833.138","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis575"},{"key":"2025120518553364000_4.6.e004833.139","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr206"},{"key":"2025120518553364000_4.6.e004833.140","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3156.1998.00316.x"},{"key":"2025120518553364000_4.6.e004833.141","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jcv.2012.06.004","article-title":"Epidemiology of varicella in Mexico","volume":"55","author":"Vergara-Casta\u00f1eda","year":"2012","journal-title":"J Clin Virol"},{"key":"2025120518553364000_4.6.e004833.142","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10315"},{"key":"2025120518553364000_4.6.e004833.143","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2010.08.014"},{"key":"2025120518553364000_4.6.e004833.144","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.15.8349-8358.2004"},{"key":"2025120518553364000_4.6.e004833.145","doi-asserted-by":"publisher","DOI":"10.3201\/eid0101.950102"},{"key":"2025120518553364000_4.6.e004833.146","doi-asserted-by":"publisher","DOI":"10.1086\/521365"},{"key":"2025120518553364000_4.6.e004833.147","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20879"},{"key":"2025120518553364000_4.6.e004833.148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071893"},{"key":"2025120518553364000_4.6.e004833.149","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.7.11.1581"},{"key":"2025120518553364000_4.6.e004833.150","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(96)01007-8"},{"key":"2025120518553364000_4.6.e004833.151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2004.06.001"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2014-004833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T02:55:56Z","timestamp":1764989756000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2014-004833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":151,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,10]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1136\/bmjopen-2014-004833"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2014-004833","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}